Omada

By Dave Muoio 02:57 pm October 11, 2019
It’s little secret that chronic conditions are a heavy burden on the healthcare system. Diabetes, heart disease, obesity and others can stick with a patient for decades, often leading to increased spending on disease management programs and costly visits when those efforts aren’t making an impact. What’s worse, many of the clinical advances of the past decade or so haven’t substantially moved the...
By Dave Muoio 03:50 pm October 10, 2019
Digital chronic disease management company Omada Health has added onto June’s $73 million funding round with a new strategic investment from Intermountain Ventures. The terms of the deal were not disclosed. WHAT THEY DO Omada pitches its digital coaching programs as a scalable and convenient approach to chronic disease management. The company’s products address hypertension, Type 2 diabetes,...

Omada CEO Sean Duffy. Photo credit: Omada

By Laura Lovett 03:57 pm July 11, 2019
Omada Health, the digital health company that recently raised $73 million, came on to the digital health scene in 2011 with a focus on diabetes and chronic conditions. As the company continues to carve out its legacy in the digital health world, it is taking a cue from a more established industry. “We’re one of the most life sciences-like digital health companies. We don’t fit perfectly into any...
By Dave Muoio 02:22 pm June 26, 2019
San Francisco-based digital chronic disease management company Omada Health has closed a $73 million funding round led by Wellington Management Company. Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures also contributed. WHAT THEY DO Omada offers a slew of digital...
By Jonah Comstock 09:01 am March 12, 2019
San Francisco-based digital chronic disease managment company Omada Health announced today that it will add fully integrated, cellular-connected glucometers and blood pressure cuffs to its offerings for Type 2 diabetes and hypertension, respectively. The devices are FDA-cleared and can be mailed to program members. The glucometer will come with as many free test strips as users need, the company...
By Dave Muoio 04:19 pm November 14, 2018
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...
By Jonah Comstock 11:26 pm September 18, 2018
Cigna and digital diabetes prevention program Omada Health are once again expanding their relationship, offering Omada's services to all of Cigna's regional and national employer customers, representing a significant portion of Cigna members. "We will be expanding in January of this year to our national and regional clients, which is a large percentage of Cigna’s book of business, but it will be...
By Laura Lovett 02:04 pm April 4, 2018
Correction: A previous version of this article misstated the year Livongo was founded. It has also been updated to accurately reflect the company's funding history.  Blue Cross Blue Shield of Massachusetts has secured its place as a digital health player with the announcement that it is launching a new portfolio of digital tools is it calling its Emerging Solutions platform. The initial offerings...
By Heather Mack 03:48 pm February 22, 2017
Digital diabetes management company Omada Health has brought on federal policy veteran Lucia Savage as their new Chief Privacy and Regulatory Officer. Savage, who previously worked as Chief Privacy Officer at the Office of the National Coordinator for IT, will lead Omada’s legal and compliance team. In her new role, Savage will lead Omada’s regulatory strategy and ensure the privacy and security...
By Jonah Comstock 04:33 pm September 16, 2016
At the Digital Medicine Connect in Boston this week, presenters wrestled with the question of what it would take to spur wider adoption of digital therapies. With Omada CEO Sean Duffy on the panel, it’s not surprising that one common answer — more and better efficacy data — came up. But also, speakers including Vidya Raman-Tangella, head of United Healthcare’s Innovation Center of Excellence and...